Position in SRPT
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$64,604,243
+$5,877,347 QoQ
Shares Held
2,968,945
+8.8% QoQ
Ownership
2.81%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 87.57319519223158.ToString("F0")%
Shared 0.ToString("F0")%
None 12.426804807768416.ToString("F0")%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Erste Asset Management GmbH holds $563,481,319 across 72 Biotechnology names. SRPT ranks #3 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,704,900 | $91,506,767 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
160,210 | $83,865,128 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
This page
|
2,968,945 | $64,604,243 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
57,209 | $44,201,961 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
91,958 | $41,062,925 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
210,000 | $19,399,800 | |
| 7 | REPL |
Replimune Group, Inc.
|
2,120,000 | $16,218,000 | |
| 8 | STOK |
Stoke Therapeutics, Inc.
|
446,000 | $14,521,760 |
All Filings in SRPT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $64,604,243 | 2,968,945 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $58,726,896 | 2,728,945 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $51,758,160 | 2,685,945 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $27,726,196 | 1,621,415 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $67,717,168 | 1,061,065 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $86,115,873 | 708,248 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $79,438,157 | 636,065 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $82,381,200 | 521,400 | Shares | Sole | 2024-11-26 | |
| 2024-03-31 | $73,973,444 | 571,400 | Shares | Sole | 2024-11-26 | |
| 2023-12-31 | $67,636,002 | 701,400 | Shares | Sole | 2024-11-26 | |
| 2023-09-30 | $83,084,188 | 685,400 | Shares | Sole | 2024-11-26 | |
| 2023-06-30 | $82,552,887 | 720,860 | Shares | Sole | 2024-11-26 | |
| 2023-03-31 | $89,432,373 | 648,860 | Shares | Sole | 2024-11-26 | |
| 2022-12-31 | $79,613,952 | 614,400 | Shares | Sole | 2024-11-26 | |
| 2022-09-30 | $74,267,404 | 671,860 | Shares | Sole | 2024-11-26 | |
| 2022-06-30 | $58,383,345 | 778,860 | Shares | Sole | 2024-11-26 | |
| 2022-03-31 | $60,844,543 | 778,860 | Shares | Sole | 2024-11-25 | |
| 2021-12-31 | $77,520,443 | 860,860 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $78,890,988 | 853,060 | Shares | Sole | 2024-11-25 | |
| 2021-06-30 | $63,984,684 | 823,060 | Shares | Sole | 2024-11-25 | |
| 2021-03-31 | $47,815,466 | 641,560 | Shares | Sole | 2024-11-25 | |
| 2020-12-31 | $64,839,051 | 380,310 | Shares | Sole | 2024-11-25 | |
| 2020-09-30 | $52,290,514 | 372,360 | Shares | Sole | 2024-11-25 | |
| 2020-06-30 | $64,338,028 | 401,260 | Shares | Sole | 2024-11-22 | |
| 2020-03-31 | $41,696,753 | 426,260 | Shares | Sole | 2024-11-22 | |
| No filing history on record for this holder in this stock. | ||||||